Reply: Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?

Affiliations

¹ Department of Paediatric Gastroenterology, University Hospital Southampton, Southampton, United Kingdom.
² Human Genetics and Genomic Medicine, University of Southampton, Southampton, United Kingdom.

Comment

Tracy Coelho et al. Inflamm Bowel Dis. 2024.

. 2024 Oct 3;30(10):1928-1930.

doi: 10.1093/ibd/izae130.

¹ Department of Paediatric Gastroenterology, University Hospital Southampton, Southampton, United Kingdom.
² Human Genetics and Genomic Medicine, University of Southampton, Southampton, United Kingdom.

No abstract available

Comment in

Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?
Sharip MT, Parkes M, Subramanian S. Sharip MT, et al. Inflamm Bowel Dis. 2024 Dec 5;30(12):2521-2522. doi: 10.1093/ibd/izae125. Inflamm Bowel Dis. 2024. PMID: 39011862

Pharmacogenomic Assessment of Genes Implicated in Thiopurine Metabolism and Toxicity in a UK Cohort of Pediatric Patients With Inflammatory Bowel Disease.
Coelho T, Cheng G, Lewis S, Ashton JJ, Barakat F, Driscoll KCT, Sholeye-Bolaji AE, Batra A, Afzal NA, Beattie RM, Ennis S. Coelho T, et al. Inflamm Bowel Dis. 2025 Feb 6;31(2):362-375. doi: 10.1093/ibd/izae126. Inflamm Bowel Dis. 2025. PMID: 39011784
Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?
Sharip MT, Parkes M, Subramanian S. Sharip MT, et al. Inflamm Bowel Dis. 2024 Dec 5;30(12):2521-2522. doi: 10.1093/ibd/izae125. Inflamm Bowel Dis. 2024. PMID: 39011862